LAURA
GONZÁLEZ COFRADE
Predoctoral FPU
Instituto de Salud Carlos III
Madrid, EspañaPublicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (3)
2022
-
Dehydroisohispanolone as a Promising NLRP3 Inhibitor Agent: Bioevaluation and Molecular Docking
Pharmaceuticals, Vol. 15, Núm. 7
2020
-
Current status of terpenoids as inflammasome inhibitors
Biochemical Pharmacology, Vol. 172
-
Dehydrohispanolone Derivatives Attenuate the Inflammatory Response through the Modulation of Inflammasome Activation
Journal of Natural Products, Vol. 83, Núm. 7, pp. 2155-2164